6.28 B
About Apteki 36,6
Sector
Industry
CEO
Alexander Kuzin
Website
Headquarters
Moscow
Founded
1991
ISIN
RU0008081765
Pharmacy Chain 36.6 PJSC engages in the retail trade of pharmaceutical products. It also offers health, wellness and personal care items. The company was founded by Artem Albertovich Bektemirov and Sergey Anatolievich Krivosheev in 1991 and is headquartered in Moscow, Russia.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of APTK is 10.050 RUB — it has increased by 7.23% in the past 24 hours. Watch Apteki 36,6 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on RUS exchange Apteki 36,6 stocks are traded under the ticker APTK.
APTK stock has risen by 0.62% compared to the previous week, the month change is a −4.16% fall, over the last year Apteki 36,6 has showed a −26.96% decrease.
APTK reached its all-time high on May 8, 2007 with the price of 2,700.000 RUB, and its all-time low was 0.650 RUB and was reached on Apr 6, 2005. View more price dynamics on APTK chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
APTK stock is 8.02% volatile and has beta coefficient of 0.09. Track Apteki 36,6 stock price on the chart and check out the list of the most volatile stocks — is Apteki 36,6 there?
Yes, you can track Apteki 36,6 financials in yearly and quarterly reports right on TradingView.
No, APTK doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, APTK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Apteki 36,6 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Apteki 36,6 technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Apteki 36,6 stock shows the sell signal. See more of Apteki 36,6 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.